Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Sandhu JS, Bixler BR, Dahm P et al (2024) Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline amendment. J Urol 211:11–19
2. Gravas S, Cornu JN, Gacci M et al (2000) EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), including benign prostatic obstruction (BPO). https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Management-of-Non-Neurogenic-Male-LUTS-2021.pdf. Access 24 Nov. 2023
3. McWilliams JP, Bilhim TA, Carnevale FC et al (2019) Society of Interventional Radiology multisociety consensus position statement on prostatic artery embolization for treatment of lower urinary tract symptoms attributed to benign prostatic hyperplasia: from the Society of Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, Société Française de Radiologie, and the British Society of Interventional Radiology. Endorsed by the Asia Pacific Society of Cardiovascular and Interventional Radiology, Canadian Association for Interventional Radiology, Chinese College of Interventionalists, Interventional Radiology Society of Australasia, Japanese Society of Interventional Radiology, and Korean Society of Interventional Radiology. J Vasc Interv Radiol 30:627–637
4. Cornelis FH, Bilhim T, Hacking N, Sapoval M, Tapping CR, Carnevale FC (2020) CIRSE standards of practice on prostatic artery embolisation. Cardiovasc Interv Radiol 43:176–185
5. Bilhim T, McWilliams JP, Bagla S (2024) Updated American Urological Association Guidelines for the Management of Benign Prostatic Hyperplasia: prostatic artery embolization made it into the guidelines! Cardiovasc Intervent Radiol 47:150–153